Genetic disorders and birth defects account for 30% of morbidity and 40% of mortality in neonatal intensive care units (NICUs).
1-5 Overlapping clinical features in this age group make reaching a diagnosis by standard-of-care testing challenging. It is hypothesized that early etiologic diagnosis, facilitated by next-generation sequencing, has the potential to revolutionize clinical care, improve prognosis, and offer precision life-saving therapy or aid in palliative care decisions in critically ill neonates.
6 Next-generation sequencing has been proven superior to standard-of-care testing in providing an accurate diagnosis.
7-9